SerpinB2 protection of retinoblastoma protein from calpain enhances tumor cell survival

Cancer Research

Volumn 68, Issue 14, 2008, Pages 5648-5657

  Tonnetti, Laura ^a,c   Netzel Arnett, Sarah ^a   Darnell, Grant A ^b   Hayes, Tamara ^a   Buzza, Marguerite S ^a   Anglin, Ian E ^a   Suhrbier, Andreas ^b   Antalis, Toni M ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^c HOLLAND LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALPAIN; CALPASTATIN; LYSINE; PLASMINOGEN ACTIVATOR INHIBITOR 2; PROTEASOME; RETINOBLASTOMA PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER STAGING; CELL PROLIFERATION; CELL PROTECTION; CELL SURVIVAL; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; FEMALE; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; PAPILLOMA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN DEPLETION; PROTEIN FUNCTION; PROTEIN METABOLISM; SKIN CARCINOGENESIS; ANIMAL; FIBROBLAST; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION; GENETICS; HELA CELL; LEUKEMIA CELL LINE; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION; SKIN TUMOR;

ANIMALS; APOPTOSIS; CALPAIN; CELL SURVIVAL; FIBROBLASTS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC PREDISPOSITION TO DISEASE; HELA CELLS; HUMANS; JURKAT CELLS; MICE; PLASMINOGEN ACTIVATOR INHIBITOR 2; RETINOBLASTOMA PROTEIN; SIGNAL TRANSDUCTION; SKIN NEOPLASMS;

EID: 48649098028     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-07-5850     Document Type: Article

References (48)

1. Du W, Pogoriler J. Retinoblastoma family genes. Oncogene 2006;25:5190-200.
2. Chau BN, Wang JY. Coordinated regulation of life and death by RB. Nat Rev Cancer 2003;3:130-8.
3. Jacks T, Fazeli A, Schmitt EM, Bronson RT, Goodell MA, Weinberg RA. Effects of an Rb mutation in the mouse. Nature 1992;359:295-300.
4. Ruiz S, Santos M, Lara MF, Segrelles C, Ballestin C, Paramio JM. Unexpected roles for pRb in mouse skin carcinogenesis. Cancer Res 2005;65:9678-86.
5. Young AP, Longmore GD. Differential regulation of apoptotic genes by Rb in human versus mouse cells. Oncogene 2004;23:2587-99.
6. Wang JY. Nucleo-cytoplasmic communication in apoptotic response to genotoxic and inflammatory stress. Cell Res 2005;15:43-8.
7. DeGregori J, Leone G, Miron A, Jakoi L, Nevins JR. Distinct roles for E2F proteins in cell growth control and apoptosis. Proc Natl Acad Sci U S A 1997;94:7245-50.
8. Muller H, Bracken AP, Vernell R, et al. E2Fs regulate the expression of genes involved in differentiation, development, proliferation, and apoptosis. Genes Dev 2001;15:267-85.
9. Nahle Z, Polakoff J, Davuluri RV, et al. Direct coupling of the cell cycle and cell death machinery by E2F. Nat Cell Biol 2002;4:859-64.
10. Darnell GA, Antalis TM, Johnstone RW, et al. Inhibition of retinoblastoma protein degradation by interaction with the serpin plasminogen activator inhibitor 2 via a novel consensus motif. Mol Cell Biol 2003;23:6520-32.
11. Kruithof EK, Baker MS, Bunn CL. Biological and clinical aspects of plasminogen activator inhibitor type 2. Blood 1995;86:4007-24.
12. Kumar S, Baglioni C. Protection from tumor necrosis factor-mediated cytolysis by overexpression of plasminogen activator inhibitor type-2. J Biol Chem 1991;266:20960-4.
13. Kasyapa CS, Kunapuli P, Hawthorn L, Cowell JK. Induction of the plasminogen activator inhibitor-2 in cells expressing the ZNF198/FGFR1 fusion kinase that is involved in atypical myeloproliferative disease. Blood 2006;107:3693-9.
14. Varro A, Noble PJ, Pritchard DM, et al. Helicobacter pylori induces plasminogen activator inhibitor 2 in gastric epithelial cells through nuclear factor-κB and RhoA. Implications for invasion and apoptosis. Cancer Res 2004;64:1695-702.
15. Zhou HM, Bolon I, Nichols A, Wohlwend A, Vassalli JD. Overexpression of plasminogen activator inhibitor type 2 in basal keratinocytes enhances papilloma formation in transgenic mice. Cancer Res 2001;61:970-6.
16. Antalis TM, La Linn M, Donnan K, et al. The serine proteinase inhibitor (serpin) plasminogen activation inhibitor type 2 protects against viral cytopathic effects by constitutive interferon α/β priming. J Exp Med 1998;187:1799-811.
17. Losick VP, Isberg RR. NF-nB translocation prevents host cell death after low-dose challenge by Legionella pneumophila. J Exp Med 2006;203:2177-89.
18. Dickinson JL, Bates EJ, Ferrante A, Antalis TM. Plasminogen activator inhibitor type 2 inhibits tumor necrosis factor α-induced apoptosis. Evidence for an alternate biological function. J Biol Chem 1995;270:27894-904.
19. Gan H, Newman GW, Remold HG. Plasminogen activator inhibitor type 2 prevents programmed cell death of human macrophages infected with Mycobacterium avium, serovar 4. J Immunol 1995;155:1304-15.
20. Pytel BA, Peppel K, Baglioni C. Plasminogen activator inhibitor type-2 is a major protein induced in human fibroblasts and SK-MEL-109 melanoma cells by tumor necrosis factor. J Cell Physiol 1990;144:416-22.
21. Helt AM, Galloway DA. Mechanisms by which DNA tumor virus oncoproteins target the Rb family of pocket proteins. Carcinogenesis 2003;24:159-69.
22. Ying H, Xiao ZX. Targeting retinoblastoma protein for degradation by proteasomes. Cell Cycle 2006;5:506-8.
23. Tan X, Wang JY. The caspase-RB connection in cell death. Trends Cell Biol 1998;8:116-20.
24. Tan X, Martin SJ, Green DR, Wang JY. Degradation of retinoblastoma protein in tumor necrosis factorand CD95-induced cell death. J Biol Chem 1997;272:9613-16.
25. Chau BN, Borges HL, Chen TT, Masselli A, Hunton IC, Wang JY. Signal-dependent protection from apoptosis in mice expressing caspase-resistant Rb. Nat Cell Biol 2002;4:757-65.
26. Goll DE, Thompson VF, Li H, Wei W, Cong J. The calpain system. Physiol Rev 2003;83:731-801.
27. Sato K, Kawashima S. Calpain function in the modulation of signal transduction molecules. Biol Chem 2001;382:743-51.
28. Arthur JS, Elce JS, Hegadorn C, Williams K, Greer PA. Disruption of the murine calpain small subunit gene, Capn4. calpain is essential for embryonic development but not for cell growth and division. Mol Cell Biol 2000;20:4474-81.
29. Raser KJ, Posner A, Wang KK. Casein zymography. a method to study A-calpain, μ-calpain, and their inhibitory agents. Arch Biochem Biophys 1995;319:211-16.
30. Dougherty KM, Pearson JM, Yang AY, Westrick RJ, Baker MS, Ginsburg D. The plasminogen activator inhibitor-2 gene is not required for normal murine development or survival. Proc Natl Acad Sci U S A 1999;96:686-91.
31. Chandra J, Niemer I, Gilbreath J, et al. Proteasome inhibitors induce apoptosis in glucocorticoid-resistant chronic lymphocytic leukemic lymphocytes. Blood 1998;92:4220-9.
32. Tompa P, Buzder-Lantos P, Tantos A, et al. On the sequential determinants of calpain cleavage. J Biol Chem 2004;279:20775-85.
33. Johnson DE. Noncaspase proteases in apoptosis. Leukemia 2000;14:1695-703.
34. Young AP, Longmore GD. Differences in stability of repressor complexes at promoters underlie distinct roles for Rb family members. Oncogene 2004;23:814-23.
35. Ruiz S, Santos M, Paramio JM. Is the loss of pRb essential for the mouse skin carcinogenesis? Cell Cycle 2006;5:625-9.
36. Hennings H, Glick AB, Lowry DT, Krsmanovic LS, Sly LM, Yuspa SH. FVB/N mice. an inbred strain sensitive to the chemical induction of squamous cell carcinomas in the skin. Carcinogenesis 1993;14:2353-8.
37. Scott KA, Moore RJ, Arnott CH, et al. An anti-tumor necrosis factor-α antibody inhibits the development of experimental skin tumors. Mol Cancer Ther 2003;2:445-51.
38. Tan Y, Wu C, De Veyra T, Greer PA. Ubiquitous calpains promote both apoptosis and survival signals in response to different cell death stimuli. J Biol Chem 2006;281:17689-98.
39. Whitaker LL, Su H, Baskaran R, Knudsen ES, Wang JY. Growth suppression by an E2F-binding-defective retinoblastoma protein (RB). contribution from the RB C pocket. Mol Cell Biol 1998;18:4032-42.
40. Dick FA, Dyson N. pRB contains an E2F1-specific binding domain that allows E2F1-induced apoptosis to be regulated separately from other E2F activities. Mol Cell 2003;12:639-49.
41. Remold-O'Donnell E. The ovalbumin family of serpin proteins. FEBS Lett 1993;315:105-8.
42. Bird PI. Serpins and regulation of cell death. Results Probl Cell Differ 1998;24:63-89.
43. Suminami Y, Nagashima S, Vujanovic NL, Hirabayashi K, Kato H, Whiteside TL. Inhibition of apoptosis in human tumour cells by the tumour-associated serpin, SCC antigen-1. Br J Cancer 2000;82:981-9.
44. Takeda A, Kajiya A, Iwasawa A, Nakamura Y, Hibino T. Aberrant expression of serpin squamous cell carcinoma antigen 2 in human tumor tissues and cell lines. evidence of protection from tumor necrosis factor-mediated apoptosis. Biol Chem 2002;383:1231-6.
45. Schleef RR, Chuang TL. Protease inhibitor 10 inhibits tumor necrosis factor α-induced cell death. Evidence for the formation of intracellular high Mr protease inhibitor 10-containing complexes. J Biol Chem 2000;275:26385-9.
46. Welss T, Sun J, Irving JA, et al. Hurpin is a selective inhibitor of lysosomal cathepsin Land protects keratinocytes from ultraviolet-induced apoptosis. Biochemistry 2003;42:7381-9.
47. Bailey CM, Khalkhali-Ellis Z, Seftor EA, Hendrix MJ. Biological functions of maspin. J Cell Physiol 2006;209:617-24.
48. Ruiz S, Santos M, Segrelles C, et al. Unique and overlapping functions of pRb and p107 in the control of proliferation and differentiation in epidermis. Development 2004;131:2737-48.